Егор Александрович Круглов
Егор Александрович Круглов has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Vladimir M. Unguryan
Kostroma Regional Oncology Dispensary
8 shared publications - Yu.A. Pobedintseva
Kostroma Oncology Dispensary
7 shared publications - Andrei Dmitrievich Kaprin
National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036 Obninsk, Russia
6 shared publications - Sergey Anatolyevich Ivanov
A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
5 shared publications Ю. А. Побединцева
ОГБУЗ “Костромской онкологический диспансер
5 shared publicationsE. V. Filimonov
Kostroma Regional Oncology Center
4 shared publications
Latest Publications
- 24 October 2023
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 12 (5)
Surgical treatment for metastases of uveal melanoma in the liver
В статье описано хирургическое лечение пациентки 43 лет с метастазами увеальной меланомы в печени. В 2016 г. пациентка заметила острое снижение зрения. Был установлен диагноз: «злокачественное новообразование сосудистой оболочки». Выполнена брахитерапия. 15.04.22 при контрольном обследовании, по данным МРТ, обнаружены метастазы в сегментах SV, SVI печени. По данным трепанобиопсии установлено наличие метастазов увеальной меланомы в печени. Во время консилиума в составе онколога, хирурга, гинеколога, анестезиолога, реаниматолога принято решение о реализации оперативного лечения: изолированная артериопортальная химиогипертермическая перфузия печени мелфаланом.Послеоперационный период протекал без особенностей. Пациентка выписана из учреждения в удовлетворительном состоянии на 16-е сутки после операции.
- 24 October 2023
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 12 (5)
Surgical treatment for metastases of uveal melanoma in the liver
В статье описано хирургическое лечение пациентки 43 лет с метастазами увеальной меланомы в печени. В 2016 г. пациентка заметила острое снижение зрения. Был установлен диагноз: «злокачественное новообразование сосудистой оболочки». Выполнена брахитерапия. 15.04.22 при контрольном обследовании, по данным МРТ, обнаружены метастазы в сегментах SV, SVI печени. По данным трепанобиопсии установлено наличие метастазов увеальной меланомы в печени. Во время консилиума в составе онколога, хирурга, гинеколога, анестезиолога, реаниматолога принято решение о реализации оперативного лечения: изолированная артериопортальная химиогипертермическая перфузия печени мелфаланом.Послеоперационный период протекал без особенностей. Пациентка выписана из учреждения в удовлетворительном состоянии на 16-е сутки после операции.
- Open Access
- 18 May 2023
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 10 (2) , 21-30
Evaluation of nerve‑sparing radical hysterectomy introduction efficiency in the regional cancer center
The purpose of the study. To evaluate the immediate and long–term results of the introduction of nerve‑s paring radical hysterectomy into the practice of the center, namely, the frequency of complications, duration of surgery, blood loss, genitourinary disorders and compare the data obtained with the data of the world literature on this issue.Patients and methods. In the period from August 2019 to October 2022, 55 patients diagnosed with cervical carcinoma who underwent nerve‑ sparing radical hysterectomy type III/C1 were treated in the conditions of the regional clinical oncological dispensary. The age category ranged from 31 to 69 years, the average age was 47.3 years. The following postoperative indicators were analyzed: duration of surgery, blood loss, amount of residual urine, duration of hospital stay after surgery, complications, mortality, number of lymph nodes examined. The analysis of long‑term oncological results in patients with a follow‑up period of more than 12 months (42–12 months) was carried out, the frequency of relapses, the frequency of progression, and mortality from progression were estimated.Results. The obtained postoperative averages, such as: the duration of the operation, amounted to 286 minutes; blood loss – 216.1 ml, the volume of residual urine on the 5th day 52.4 ml, the duration of hospital stay after surgery 11.1 days, complications of the II degree according to Clavien–Dindo – 3.6 %, complications of the III degree according to Clavien‑ Dindo – 3.6 %, there was no postoperative mortality, the number of lymph nodes examined was 18.3. During the follow‑up period, the recurrence rate was 0 %, relapse‑free survival was 91 %, progression and mortality from progression were 7 % and 3.5 (4 and 2 patients), respectively. The effectiveness of the implementation of the methodology was evaluated by comparing it with the data given in the world literature on a similar issue. At the same time, it was found that the duration of the operation, blood loss, the frequency of complications and genitourinary disorders, the frequency of relapse and progression did not differ significantly from the data of the international literature.Conclusion. The introduction of the technology of nerve‑ sparing hysterectomy of the uterus type III/C1, in cervical cancer surgery is relatively safe and approachable in a regional oncology hospital.
- 18 May 2023
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 10 (2) , 21-30
Open AccessEvaluation of nerve‑sparing radical hysterectomy introduction efficiency in the regional cancer center
The purpose of the study. To evaluate the immediate and long–term results of the introduction of nerve‑s paring radical hysterectomy into the practice of the center, namely, the frequency of complications, duration of surgery, blood loss, genitourinary disorders and compare the data obtained with the data of the world literature on this issue.Patients and methods. In the period from August 2019 to October 2022, 55 patients diagnosed with cervical carcinoma who underwent nerve‑ sparing radical hysterectomy type III/C1 were treated in the conditions of the regional clinical oncological dispensary. The age category ranged from 31 to 69 years, the average age was 47.3 years. The following postoperative indicators were analyzed: duration of surgery, blood loss, amount of residual urine, duration of hospital stay after surgery, complications, mortality, number of lymph nodes examined. The analysis of long‑term oncological results in patients with a follow‑up period of more than 12 months (42–12 months) was carried out, the frequency of relapses, the frequency of progression, and mortality from progression were estimated.Results. The obtained postoperative averages, such as: the duration of the operation, amounted to 286 minutes; blood loss – 216.1 ml, the volume of residual urine on the 5th day 52.4 ml, the duration of hospital stay after surgery 11.1 days, complications of the II degree according to Clavien–Dindo – 3.6 %, complications of the III degree according to Clavien‑ Dindo – 3.6 %, there was no postoperative mortality, the number of lymph nodes examined was 18.3. During the follow‑up period, the recurrence rate was 0 %, relapse‑free survival was 91 %, progression and mortality from progression were 7 % and 3.5 (4 and 2 patients), respectively. The effectiveness of the implementation of the methodology was evaluated by comparing it with the data given in the world literature on a similar issue. At the same time, it was found that the duration of the operation, blood loss, the frequency of complications and genitourinary disorders, the frequency of relapse and progression did not differ significantly from the data of the international literature.Conclusion. The introduction of the technology of nerve‑ sparing hysterectomy of the uterus type III/C1, in cervical cancer surgery is relatively safe and approachable in a regional oncology hospital.
- Open Access
- 7 June 2022
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 27 (2) , 115-120
Isolated cavaportal hepatic chemoperfusion using melphalan in the treatment of uveal melanoma liver metastases
A rare clinical observation of using hyperthermic isolated hepatic chemoperfusion is considered in the setting of a pathologically altered hepatic arterial blood flow in focal hepatic lesions caused by uveal melanoma metastases. The technical feasibility and safety of performing hyperthermic isolated hepatic chemoperfusion through the portal vein against the background of the altered hepatic arterial bed were demonstrated.
- 7 June 2022
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 27 (2) , 115-120
Open AccessIsolated cavaportal hepatic chemoperfusion using melphalan in the treatment of uveal melanoma liver metastases
A rare clinical observation of using hyperthermic isolated hepatic chemoperfusion is considered in the setting of a pathologically altered hepatic arterial blood flow in focal hepatic lesions caused by uveal melanoma metastases. The technical feasibility and safety of performing hyperthermic isolated hepatic chemoperfusion through the portal vein against the background of the altered hepatic arterial bed were demonstrated.
- Open Access
- 1 June 2022
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 12 (1) , 5-12
Comparative Assessment of Isolated Liver Chemoperfusion Techniques
Background. Metastatic liver injury is a distinct oncological problem, irrespective of primary malignancy. Resection surgery is not always feasible in such patients. Isolated liver chemoperfusion is a promising treatment option in multiple small-focal metastatic organic lesions. This technique is technically complex, which limits its broader evaluation and adoption in clinical practice. The diversity of isolated liver chemoperfusion techniques does not allow an adequate assessment of world experience and requires further research. The important considerations with introducing isolated liver chemoperfusion are: an optimal surgical technique, liver isolation control method, as well as physiological arterial and portal blood flow maintenance.Materials and methods. A total of 21 patients were surveyed over June 2020 — December 2021. The patients were divided into 3 prospective cohorts: A) arteriocaval chemoperfusion, midline laparotomy access, technical-guided liver isolation, B) arteriocaval chemoperfusion, “in J laparotomy” access, ICG-guided liver isolation, C) arterio-porto-caval chemoperfusion, “in J laparotomy” access, ICG-guided liver isolation. A procedure’s tolerance was assessed with: the duration of surgery, postoperative ICU bed-days, total postoperative bed-days, hepatic cytolysis rates, chemotherapy side-effects severity.Results and discussion. The duration of surgery shortened with “in J laparotomy”. Haemotoxicity did not differ between cohorts A and B, albeit appearing significantly lower in cohort C. The cytolytic syndrome duration statistically significantly reduced in C vs. A and B cohorts.Conclusion. All the isolated liver chemoperfusion techniques employed are patient-safe. In ICG-guided liver isolation, the agent leakage into systemic blood flow is less likely, indicating a lower haemotoxicity. Arterioportal isolated chemoperfusion is more physiological compared to other techniques, thus facilitating lower hepatotoxicity. The use of “in J laparotomy” significantly reduces liver mobilisation and vascular cannulation times.
- 1 June 2022
- Published by Bashkir State Medical University in Creative surgery and oncology
- Vol. 12 (1) , 5-12
Open AccessComparative Assessment of Isolated Liver Chemoperfusion Techniques
Background. Metastatic liver injury is a distinct oncological problem, irrespective of primary malignancy. Resection surgery is not always feasible in such patients. Isolated liver chemoperfusion is a promising treatment option in multiple small-focal metastatic organic lesions. This technique is technically complex, which limits its broader evaluation and adoption in clinical practice. The diversity of isolated liver chemoperfusion techniques does not allow an adequate assessment of world experience and requires further research. The important considerations with introducing isolated liver chemoperfusion are: an optimal surgical technique, liver isolation control method, as well as physiological arterial and portal blood flow maintenance.Materials and methods. A total of 21 patients were surveyed over June 2020 — December 2021. The patients were divided into 3 prospective cohorts: A) arteriocaval chemoperfusion, midline laparotomy access, technical-guided liver isolation, B) arteriocaval chemoperfusion, “in J laparotomy” access, ICG-guided liver isolation, C) arterio-porto-caval chemoperfusion, “in J laparotomy” access, ICG-guided liver isolation. A procedure’s tolerance was assessed with: the duration of surgery, postoperative ICU bed-days, total postoperative bed-days, hepatic cytolysis rates, chemotherapy side-effects severity.Results and discussion. The duration of surgery shortened with “in J laparotomy”. Haemotoxicity did not differ between cohorts A and B, albeit appearing significantly lower in cohort C. The cytolytic syndrome duration statistically significantly reduced in C vs. A and B cohorts.Conclusion. All the isolated liver chemoperfusion techniques employed are patient-safe. In ICG-guided liver isolation, the agent leakage into systemic blood flow is less likely, indicating a lower haemotoxicity. Arterioportal isolated chemoperfusion is more physiological compared to other techniques, thus facilitating lower hepatotoxicity. The use of “in J laparotomy” significantly reduces liver mobilisation and vascular cannulation times.
- 1 January 2022
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 44 (2)
Transarterial chemoembolization and isolated liver chemoperfusion in the treatment of uveal melanoma in patients with liver metastases (a systematic review)
ЦЕЛЬ СИСТЕМАТИЧЕСКОГО ОБЗОРА Сравнить методы трансартериальной химиоэмболизации и изолированной химиоперфузии печени путем оценки их безопасности, непосредственных и отдаленных результатов применения у больных с метастазами увеальной меланомы в печень. МАТЕРИАЛ И МЕТОДЫ Проведен систематический поиск литературы (базы данных PubMed, eLibrary, Cochrane Library) в соответствии с рекомендациями PRISMA 2020 (оформление чек-листа и построение блок-схемы), в результате отобраны 7 исследований. Критерии отбора клинических исследований следующие: метастазы увеальной меланомы в печень, трансартериальная химиоэмболизация, изолированная химиоперфузия печени. В качестве исходов выбраны такие показатели, как послеоперационная летальность, частота объективного ответа, общая выживаемость и безрецидивная выживаемость. В исследованиях, включенных в систематический обзор, изучаемые исходы анализировали при помощи построения кривых Каплана—Мейера. РЕЗУЛЬТАТЫ Частота объективного ответа, общая и безрецидивная выживаемость оказались статистически значимо выше у пациентов группы с применением изолированной химиоперфузии печени. При этом частота развития осложнений и послеоперационной летальности была статистически значимо ниже в группе с применением трансартериальной химиоэмболизации. ЗАКЛЮЧЕНИЕ Применение метода изолированной химиоперфузии является перспективным направлением в лечении больных с метастазами увеальной меланомы в печень. Следует рассмотреть возможность снижения частоты послеоперационных осложнений и летальности путем разработки минимально инвазивной техники выполнения изолированной перфузии печени.
- 1 January 2022
- Published by Media Sphere Publishing Group in Medical Technologies. Assessment and Choice
- Vol. 44 (2)
Transarterial chemoembolization and isolated liver chemoperfusion in the treatment of uveal melanoma in patients with liver metastases (a systematic review)
ЦЕЛЬ СИСТЕМАТИЧЕСКОГО ОБЗОРА Сравнить методы трансартериальной химиоэмболизации и изолированной химиоперфузии печени путем оценки их безопасности, непосредственных и отдаленных результатов применения у больных с метастазами увеальной меланомы в печень. МАТЕРИАЛ И МЕТОДЫ Проведен систематический поиск литературы (базы данных PubMed, eLibrary, Cochrane Library) в соответствии с рекомендациями PRISMA 2020 (оформление чек-листа и построение блок-схемы), в результате отобраны 7 исследований. Критерии отбора клинических исследований следующие: метастазы увеальной меланомы в печень, трансартериальная химиоэмболизация, изолированная химиоперфузия печени. В качестве исходов выбраны такие показатели, как послеоперационная летальность, частота объективного ответа, общая выживаемость и безрецидивная выживаемость. В исследованиях, включенных в систематический обзор, изучаемые исходы анализировали при помощи построения кривых Каплана—Мейера. РЕЗУЛЬТАТЫ Частота объективного ответа, общая и безрецидивная выживаемость оказались статистически значимо выше у пациентов группы с применением изолированной химиоперфузии печени. При этом частота развития осложнений и послеоперационной летальности была статистически значимо ниже в группе с применением трансартериальной химиоэмболизации. ЗАКЛЮЧЕНИЕ Применение метода изолированной химиоперфузии является перспективным направлением в лечении больных с метастазами увеальной меланомы в печень. Следует рассмотреть возможность снижения частоты послеоперационных осложнений и летальности путем разработки минимально инвазивной техники выполнения изолированной перфузии печени.
- 1 January 2022
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 11 (3) , 31
Adoption of the technique of laparoscopic radical prostatectomy on the example of the regional cancer center
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить частоту осложнений, длительность операции, непосредственные и онкологические результаты при внедрении технологии минимально инвазивной радикальной простатэктомии на примере регионального онкологического центра. МАТЕРИАЛ И МЕТОДЫ Проведен ретроспективный анализ базы данных пациентов, оперированных минимально инвазивным доступом по поводу рака предстательной железы. По данной методике выполнено 50 операций, пациенты были разделены на 2 хронологические группы в зависимости от времени освоения хирургической технологии: 1-я группа — 1—30-я операция, 2-я группа — 31—50-я операция. Проанализированы следующие показатели: продолжительность операции, объем кровопотери, частота положительного хирургического края, осложнений, летальность, продолжительность уретрального дренирования, длительность пребывания в стационаре после операции. РЕЗУЛЬТАТЫ При анализе основных предоперационных показателей не выявлено существенных различий. Достоверно значимые различия (p0,05) в продолжительности уретрального дренирования (14,2±4,97 сут против 12,2±3,7 сут), длительности пребывания в стационаре после операции (16 сут против 11 сут) и частоте положительного хирургического края (13,3% против 10%). ЗАКЛЮЧЕНИЕ Внедрение технологии минимально инвазивной радикальной простатэктомии относительно безопасно и возможно в условиях регионального онкологического стационара. Несмотря на то что кривая обучения в региональной больнице еще не достигнута, результаты сопоставимы с данными, представленными в источниках литературы.
- 1 January 2022
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 11 (3) , 31
Adoption of the technique of laparoscopic radical prostatectomy on the example of the regional cancer center
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить частоту осложнений, длительность операции, непосредственные и онкологические результаты при внедрении технологии минимально инвазивной радикальной простатэктомии на примере регионального онкологического центра. МАТЕРИАЛ И МЕТОДЫ Проведен ретроспективный анализ базы данных пациентов, оперированных минимально инвазивным доступом по поводу рака предстательной железы. По данной методике выполнено 50 операций, пациенты были разделены на 2 хронологические группы в зависимости от времени освоения хирургической технологии: 1-я группа — 1—30-я операция, 2-я группа — 31—50-я операция. Проанализированы следующие показатели: продолжительность операции, объем кровопотери, частота положительного хирургического края, осложнений, летальность, продолжительность уретрального дренирования, длительность пребывания в стационаре после операции. РЕЗУЛЬТАТЫ При анализе основных предоперационных показателей не выявлено существенных различий. Достоверно значимые различия (p0,05) в продолжительности уретрального дренирования (14,2±4,97 сут против 12,2±3,7 сут), длительности пребывания в стационаре после операции (16 сут против 11 сут) и частоте положительного хирургического края (13,3% против 10%). ЗАКЛЮЧЕНИЕ Внедрение технологии минимально инвазивной радикальной простатэктомии относительно безопасно и возможно в условиях регионального онкологического стационара. Несмотря на то что кривая обучения в региональной больнице еще не достигнута, результаты сопоставимы с данными, представленными в источниках литературы.
- Open Access
- 10 December 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 117-123
Immediate results of treatment of patients with metastatic uveal melanoma using isolated liver chemoperfusion. The first domestic experience
Introduction. Uveal melanoma is the most common primary intraocular tumor in adults. Despite some achievements in primary tumor treatment, 50% of patients develop distant metastases in various times (3 years to decades). Hematogenous spread is typical for uveal melanoma, and in 90% of the cases liver is the target. Median survival of patients with liver metastases is 4 to 9 months according to various researchers. And the result of treatment is extremely poor, unlike the results of skin melanoma treatment.The aim is to evaluate the immediate results of treatment of patients with uveal melanoma metastatic to the liver using isolated hepatic perfusion technique.Materials and methods. Considering a high risk of developing a metastatic liver disease in patients with uveal melanoma, local therapy is particularly interesting. This article describes the results of 10 metastatic uveal melanoma patients’ Isolated Hepatic Perfusion (IHP) Treatment. IHP was conducted using the standard methods with 100 mg of Melphalan for 60 min.Results and discussion. IHP treatment shows low complication rate. The data for response assessment is available on 9 out of 10 patients, because 10th patient received this treatment less than a month ago. Follow-ups a month after 9 patients underwent IHP showed an objective response to treatment in 6 patients (complete response in 1, partial response in 5 patients).Conclusion. The use of isolated liver chemoperfusion in a small group of patients according to the standard procedure allowed achieving an immediate response in 67% of cases.
- 10 December 2021
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 117-123
Open AccessImmediate results of treatment of patients with metastatic uveal melanoma using isolated liver chemoperfusion. The first domestic experience
Introduction. Uveal melanoma is the most common primary intraocular tumor in adults. Despite some achievements in primary tumor treatment, 50% of patients develop distant metastases in various times (3 years to decades). Hematogenous spread is typical for uveal melanoma, and in 90% of the cases liver is the target. Median survival of patients with liver metastases is 4 to 9 months according to various researchers. And the result of treatment is extremely poor, unlike the results of skin melanoma treatment.The aim is to evaluate the immediate results of treatment of patients with uveal melanoma metastatic to the liver using isolated hepatic perfusion technique.Materials and methods. Considering a high risk of developing a metastatic liver disease in patients with uveal melanoma, local therapy is particularly interesting. This article describes the results of 10 metastatic uveal melanoma patients’ Isolated Hepatic Perfusion (IHP) Treatment. IHP was conducted using the standard methods with 100 mg of Melphalan for 60 min.Results and discussion. IHP treatment shows low complication rate. The data for response assessment is available on 9 out of 10 patients, because 10th patient received this treatment less than a month ago. Follow-ups a month after 9 patients underwent IHP showed an objective response to treatment in 6 patients (complete response in 1, partial response in 5 patients).Conclusion. The use of isolated liver chemoperfusion in a small group of patients according to the standard procedure allowed achieving an immediate response in 67% of cases.
- Open Access
- 9 December 2021
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 8 (4) , 80-86
Isolated chemohyperthermal perfusion of the liver with melphalan in the treatment of unresectable liver metastases with uveal melanoma
Uveal melanoma belongs to rare malignant neoplasms, and the biological peculiarity of this tumor determines the high rate of distant metastasis, which reaches 60 %. Most frequently, uveal melanoma metastases are localized in the liver and have an isolated character. At the same time, despite the achievements of modern drug therapy, the treatment results of this category of patients remain unsatisfactory. Among the regional methods of treatment of metastatic uveal melanoma, surgical treatment is considered to be the most effective. Median survival rate in the group of radically operated patients (R0) is 27 months. At present, in the vast majority of cases, surgical treatment is impossible because of multiple bilobar metastasis and advanced cancer process. Median life expectancy of patients with liver metastases is only 9 months. A promising method of regional treatment of inoperable metastatic uveal melanoma is isolated liver chemoperfusion. Multidisciplinary team of Radiology Scientific Research Center and Kostroma Oncologic Dispensary for the first time in Russia presents a clinical case of a patient with isolated inoperable uveal melanoma liver metastases using an innovative method - isolated high-dose chemo hyperthermic liver perfusion with melphalan. The article describes in detail the method of the procedure, estimates immediate (partial response in 1 month after the procedure) and long-term results of the method (stabilization of the condition against the background of immunotherapy in 9 months after surgery). Based on the presented clinical observation, isolated liver chemoperfusion with melphalan for this category of patients is reasonable. However, despite the encouraging immediate results, clinical experience needs to be accumulated in order to be further evaluated in clinical trials.
- 9 December 2021
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 8 (4) , 80-86
Open AccessIsolated chemohyperthermal perfusion of the liver with melphalan in the treatment of unresectable liver metastases with uveal melanoma
Uveal melanoma belongs to rare malignant neoplasms, and the biological peculiarity of this tumor determines the high rate of distant metastasis, which reaches 60 %. Most frequently, uveal melanoma metastases are localized in the liver and have an isolated character. At the same time, despite the achievements of modern drug therapy, the treatment results of this category of patients remain unsatisfactory. Among the regional methods of treatment of metastatic uveal melanoma, surgical treatment is considered to be the most effective. Median survival rate in the group of radically operated patients (R0) is 27 months. At present, in the vast majority of cases, surgical treatment is impossible because of multiple bilobar metastasis and advanced cancer process. Median life expectancy of patients with liver metastases is only 9 months. A promising method of regional treatment of inoperable metastatic uveal melanoma is isolated liver chemoperfusion. Multidisciplinary team of Radiology Scientific Research Center and Kostroma Oncologic Dispensary for the first time in Russia presents a clinical case of a patient with isolated inoperable uveal melanoma liver metastases using an innovative method - isolated high-dose chemo hyperthermic liver perfusion with melphalan. The article describes in detail the method of the procedure, estimates immediate (partial response in 1 month after the procedure) and long-term results of the method (stabilization of the condition against the background of immunotherapy in 9 months after surgery). Based on the presented clinical observation, isolated liver chemoperfusion with melphalan for this category of patients is reasonable. However, despite the encouraging immediate results, clinical experience needs to be accumulated in order to be further evaluated in clinical trials.
- Open Access
- 22 December 2020
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 7 (4) , 155-163
Case of successful treatment of a patient with ischemictracheoesophageal and tracheopleural fistulas after a mckeown hybrid esophagectomy
The occurrence of tracheal fistulas of ischemic genesis combined with the failure of esophagogastroanastomosis and the communication between them is a rare and formidable complication after esophagectomy with mediastinal lymphadenectomy due to its anatomical position and extensiveness. However, it is insufficiently documented in the literature, both in terms of treatment and in terms of its causes. This observation aims to demonstrate the rare cause of this complication and the atypical successful treatment. In this case, a patient with squamous cell carcinoma G2 of the middle third of the esophagus and TNM stage cT3NxM0. On the McKeown thoracoscopic-laparotomy esophagectomy intraoperatively a short arterial vessel with a diameter of about 3 mm, which passed through the paracancerous infiltration and supplied blood to the esophagus and trachea revealed. The vessel was not isolated from the infiltrate, but was clipped and crossed between the aorta and infiltrate to maintain surgery ablastic. On the 7th day after the operation the insolvency of esophagogastroanastomosis, the fistula of the trachea with mediastinum and the communication between the leak of esophagogastroanastomosis and the fistula of the trachea were diagnosed. We consider this combination as a special case of esophagogastroanastomosis fistula, complicated by the communication between the right pleural cavity and pneumothorax. According to our experience, partial leak of esophagogastroanastomosis successfully heals by secondary tension within 10–15 days against the background of cervicotomic wound drainage and feeding through a nasointestinal tube. In this case there was a leak of saliva in the mediastinum and its penetration into the lumen of the trachea and the right pleural cavity. Surgical diversion of the fistula and stenting of the trachea were considered, but not applied, as the fistula in our opinion was controlled, but the aggressive content of the gastric conduit prevented healing. The patient was on assisted lung ventilation with minimal pressure support and inflow increased oxygen fractio. For this reason, we considered the best stenting of the esophagogastroanastomosis leak area to be covered with a stent in order to stop the aggressive content of the gastric stem from entering the fistula, which led to the successful treatment of the developed severe complication. It should be noted that this method of treatment may be ineffective in patients who need pressure support during ventilation.
- 22 December 2020
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 7 (4) , 155-163
Open AccessCase of successful treatment of a patient with ischemictracheoesophageal and tracheopleural fistulas after a mckeown hybrid esophagectomy
The occurrence of tracheal fistulas of ischemic genesis combined with the failure of esophagogastroanastomosis and the communication between them is a rare and formidable complication after esophagectomy with mediastinal lymphadenectomy due to its anatomical position and extensiveness. However, it is insufficiently documented in the literature, both in terms of treatment and in terms of its causes. This observation aims to demonstrate the rare cause of this complication and the atypical successful treatment. In this case, a patient with squamous cell carcinoma G2 of the middle third of the esophagus and TNM stage cT3NxM0. On the McKeown thoracoscopic-laparotomy esophagectomy intraoperatively a short arterial vessel with a diameter of about 3 mm, which passed through the paracancerous infiltration and supplied blood to the esophagus and trachea revealed. The vessel was not isolated from the infiltrate, but was clipped and crossed between the aorta and infiltrate to maintain surgery ablastic. On the 7th day after the operation the insolvency of esophagogastroanastomosis, the fistula of the trachea with mediastinum and the communication between the leak of esophagogastroanastomosis and the fistula of the trachea were diagnosed. We consider this combination as a special case of esophagogastroanastomosis fistula, complicated by the communication between the right pleural cavity and pneumothorax. According to our experience, partial leak of esophagogastroanastomosis successfully heals by secondary tension within 10–15 days against the background of cervicotomic wound drainage and feeding through a nasointestinal tube. In this case there was a leak of saliva in the mediastinum and its penetration into the lumen of the trachea and the right pleural cavity. Surgical diversion of the fistula and stenting of the trachea were considered, but not applied, as the fistula in our opinion was controlled, but the aggressive content of the gastric conduit prevented healing. The patient was on assisted lung ventilation with minimal pressure support and inflow increased oxygen fractio. For this reason, we considered the best stenting of the esophagogastroanastomosis leak area to be covered with a stent in order to stop the aggressive content of the gastric stem from entering the fistula, which led to the successful treatment of the developed severe complication. It should be noted that this method of treatment may be ineffective in patients who need pressure support during ventilation.
- Open Access
- 9 September 2018
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 5 (3) , 136-141
Superior mesenteric artery injury during laparoscopic radical nephrectomy
The authors present to your a en on a rare clinical case of complete intersec on of the superior mesenteric artery in laparoscopic radical nephrectomy. This complica on emerged in the process of learning the technique of laparoscopic radical nephrectomy, before reaching the “plateau” of the learning curve, in condi ons of poor vision and in the interposi on of tissues due to paratumorous infitiltra on. This type of injury has a high risk of total necrosis of the small intestine. However, due to the concerted ac ons of the surgical service and the readiness of surgeons to complete the vascular suture of the main vessels, a successful reimplanta on of the superior mesenteric artery into the aorta was performed. This is confi rmed by postopera ve observa on and examina on, which included CT angiography. It should be noted that descrip ons of cases of aor c reimplanta on of the superior mesenteric artery are extremely rare in the world and national literature, except for cases of mesenteric ischemia. This case contributes to the description of rare cases of aor c reimplanta on of the superior mesenteric artery and shows the correctness of the selected surgical tactics.
- 9 September 2018
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 5 (3) , 136-141
Open AccessSuperior mesenteric artery injury during laparoscopic radical nephrectomy
The authors present to your a en on a rare clinical case of complete intersec on of the superior mesenteric artery in laparoscopic radical nephrectomy. This complica on emerged in the process of learning the technique of laparoscopic radical nephrectomy, before reaching the “plateau” of the learning curve, in condi ons of poor vision and in the interposi on of tissues due to paratumorous infitiltra on. This type of injury has a high risk of total necrosis of the small intestine. However, due to the concerted ac ons of the surgical service and the readiness of surgeons to complete the vascular suture of the main vessels, a successful reimplanta on of the superior mesenteric artery into the aorta was performed. This is confi rmed by postopera ve observa on and examina on, which included CT angiography. It should be noted that descrip ons of cases of aor c reimplanta on of the superior mesenteric artery are extremely rare in the world and national literature, except for cases of mesenteric ischemia. This case contributes to the description of rare cases of aor c reimplanta on of the superior mesenteric artery and shows the correctness of the selected surgical tactics.